The drug being credited with potentially saving the lives of two American missionaries infected with the deadly Ebola virus was produced in Owensboro.

The serum wasn’t manufactured but grown — in a greenhouse full of genetically modified tobacco plants.

Kentucky BioProcessing, acquired by Reynolds American in January, conducts contract research and development for San Diego-based Mapp Biopharmaceutical, said David Howard, spokesman for RAI Ser vices, a subsidiary of Reynolds American. MORE